20
Participants
Start Date
May 1, 2025
Primary Completion Date
December 31, 2029
Study Completion Date
December 31, 2029
P63+ lung progenitors
"1. Patient Screening and Cell Collection:~ Eligible patients will undergo sample collection at the study center or authorized tertiary hospitals. The operator will collect samples via bronchial brushing from three healthy segments of the patient's 3-5 level bronchi. The samples will be transported to a cooperative production facility for isolation and preparation. The cell preparation cycle is approximately 4-8 weeks. Patients will bear the costs of this process.~2. Transplantation Therapy:~ Transplantation therapy will be conducted at Ruijin Hainan Hospital. The cell preparation will be administered via fiberoptic bronchoscopy to each lung segment, with one dose per patient. After infusion, patients are advised to remain hospitalized for 24-48 hours for observation.~3. Post-Treatment Follow-Up:~Patients are advised to return for examination and evaluation at 4 and 24 weeks post-treatment."
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
Ruijin Hospital
OTHER